Matthew L. Crawley - Concepedia

Author

Matthew L. Crawley

Incyte (United States)

Also Known As

Crawley, M.L., M. L. CRAWLEY, M. L. Crawley, Matthew L. Crawley, Matthew Lantz Crawley

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Incyte (United States)Experimental Station Stanford University

About

Matthew L. Crawley is an author at Incyte (United States) specializing in biochemistry, chemistry, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	7	7	367
2	Medicine	5	5	278
3	Engineering	4	4	135
4	Natural Sciences	4	4	244
5	Health Sciences	1	1	53

Matthew L. Crawley

Publications

808

Citations

H-Index

Page 1

	Year	Citations
4-Aryloxybutenolides As “Chiral Aldehyde” Equivalents: An Efficient Enantioselective Synthesis of (+)-Brefeldin A Barry M. Trost, Matthew L. Crawley Journal of the American Chemical Society	2002	102
Structure-Based Design and Discovery of Protein Tyrosine Phosphatase Inhibitors Incorporating Novel Isothiazolidinone Heterocyclic Phosphotyrosine Mimetics Andrew P. Combs, Eddy W. Yue, Michael J. Bower, Journal of Medicinal Chemistry Molecular DockingCrystal StructureMedicinal ChemistryCombinatorial ChemistryBiochemistry	2005	101
Potent Benzimidazole Sulfonamide Protein Tyrosine Phosphatase 1B Inhibitors Containing the Heterocyclic ( <i>S</i> )-Isothiazolidinone Phosphotyrosine Mimetic Andrew P. Combs, Wenyu Zhu, Matthew L. Crawley, Journal of Medicinal Chemistry	2006	85
α-Acetoxysulfones as “Chiral Aldehyde” Equivalents Barry M. Trost, Matthew L. Crawley, Chul Bom Lee Journal of the American Chemical Society BiochemistryNatural SciencesChiral AldehydeAltmetric Attention ScoreOrganic Chemistry	2000	76
Regioselective Synthesis of Substituted Pyrroles: Efficient Palladium-Catalyzed Cyclization of Internal Alkynes and 2-Amino-3-iodoacrylate Derivatives Matthew L. Crawley, Igor Goljer, Douglas J. Jenkins, Organic Letters Chemical EngineeringEngineeringAlkene MetathesisInternal AlkynesOrganic Chemistry	2006	73
A “Chiral Aldehyde” Equivalent as a Building Block Towards Biologically Active Targets Barry M. Trost, Matthew L. Crawley Chemistry - A European Journal	2004	72
Structural Insights into the Design of Nonpeptidic Isothiazolidinone-containing Inhibitors of Protein-tyrosine Phosphatase 1B J. Paul, Lucie Gonneville, Milton C. Hillman, Journal of Biological Chemistry	2006	60
Benzothiazole benzimidazole (S)-isothiazolidinone derivatives as protein tyrosine phosphatase-1B inhibitors Richard Sparks, Padmaja Polam, Wenyu Zhu, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryBenzothiazole BenzimidazoleMedicineNatural Sciences	2006	54
Improvement of Physiochemical Properties of the Tetrahydroazepinoindole Series of Farnesoid X Receptor (FXR) Agonists: Beneficial Modulation of Lipids in Primates Joseph T. Lundquist, Douglas C. Harnish, Callain Y. Kim, Journal of Medicinal Chemistry Crystal StructurePharmaceutical ScienceFarnesoid X ReceptorPharmacotherapyTetrahydroazepinoindole Series	2010	53
Isothiazolidinone heterocycles as inhibitors of protein tyrosine phosphatases: Synthesis and structure–activity relationships of a peptide scaffold Eddy W. Yue, Brian Wayland, Brent Douty, Bioorganic & Medicinal Chemistry BiochemistryMedicinePeptide ScaffoldIsothiazolidinone HeterocyclesPeptide Synthesis	2006	46

Page 1